Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 33513 

TABLE 1—LETTERS OF AUTHORIZATION ISSUED FOR OIL AND GAS DEVELOPMENT ACTIVITIES IN THE BEAUFORT SEA, 

ALASKA, IN 2021—Continued 

Company Project LOA No. 

Conoco Philips Alaska ............................ This field-wide LOA is for activities associated with the operations at the 

Kuparuk River Unit, Colville River Unit, Greater Mooses Tooth Unit, and surrounding non-unit area. (Date issued: 08/05/2021).

21–06. 

Conoco Philips Alaska ............................ This field-wide LOA is for activities associated with the operations at the 

Kuparuk River Unit, Colville River Unit, Greater Mooses Tooth Unit, and surrounding non-unit area. (Date issued: 10/18/2021).

21–06 [Corrected]. 

Conoco Philips Alaska ............................ Construction on the Greater Mooses Tooth Two Pad/Mooses Tooth 7 within the 

National Petroleum Reserve—Alaska. (Date issued: 08/05/2021).

21–07. 

Conoco Phillips Alaska ........................... Construction on the Greater Mooses Tooth Two Pad/Mooses Tooth 7 within the 

National Petroleum Reserve–Alaska. (Date issued: 10/18/2021).

21–07 [Corrected]. 

Alyeska Pipeline Service Company ........ Operation and maintenance of the Trans Alaska Pipeline System, which extends from Pump Station 1 in the Prudhoe Bay oilfield to the Valdez Marine 

Terminal. (Date issued: 08/18/2021).

21–08. 

Alyeska Pipeline Service Company ........ Operation and maintenance of the Trans Alaska Pipeline System, which extends from Pump Station 1 in the Prudhoe Bay oilfield to the Valdez Marine 

Terminal. (Date issued: 10/18/2021).

21–08 [Corrected]. 

Conoco Philips ........................................ Activities associated with plugging and abandonment of existing exploration 

wells (Scout 1, Cassin 1, and Cassin 6) in the Bear Tooth Unit and construction and maintenance of ice pads and ice roads. (Date issued: 09/15/2021).

21–09. 

Conoco Philips Alaska ............................ Activities associated with plugging and abandonment of existing exploration 

wells (Scout 1, Cassin 1, and Cassin 6) in the Bear Tooth Unit and construction and maintenance of ice pads and ice roads. (Date issued: 12/01/2021).

21–09 [Amended]. 

SAExploration, Inc .................................. Narwhal Phase II Seismic Survey in the National Petroleum Reserve—Alaska 

and Kuukpik Corporation lands. (Date issued: 12/03/2021).

21–10. 

* The 2016–2021 ITRs were established by a final rule published at 81 FR 52276, August 5, 2016. 

On August 1, 2019, the Service 

published in the Federal Register a final 

rule (84 FR 37716) establishing 

regulations that allow us to authorize 

the nonlethal, incidental, unintentional 

take of small numbers of northern sea 

otters (Enhydra lutris kenyoni) during 

year-round oil and gas industry 

exploration, development, production, 

and transportation activities in Cook 

Inlet, Alaska. The rule established 

subpart K in part 18 of title 50 of the 

CFR and is effective through August 1, 

2024. The rule prescribes a process 

under which we issue LOAs to 

applicants conducting activities as 

described under the provisions of the 

regulations. 

Each LOA stipulates conditions or 

methods that are specific to the activity 

and location. Holders of the LOAs must 

use methods and conduct activities in a 

manner that minimizes to the greatest 

extent practicable adverse impacts on 

northern sea otters and their habitat and 

on the availability of northern sea otters 

for subsistence purposes. No intentional 

take or lethal incidental take is 

authorized under these regulations. 

In accordance with section 

101(a)(5)(A) of the Marine Mammal 

Protection Act (MMPA; 16 U.S.C. 1361 

et seq.) and our regulations at 50 CFR 

part 18, subpart K, in 2021, we issued 

an LOA to the following company in 

Cook Inlet, Alaska, as shown in table 2. 

TABLE 2—LETTER OF AUTHORIZATION ISSUED FOR OIL AND GAS DEVELOPMENT ACTIVITIES IN COOK INLET, ALASKA, IN

2021 

Company Project LOA No. 

Hilcorp Alaska ......................................... Hilcorp’s Lower Cook Inlet Outer Continental Shelf geohazard survey, Lower 

Cook Inlet exploratory drilling, North Cook Inlet Unit subsea well plug and 

abandonment activity, and routine maintenance of pipelines and platforms in 

the Cook Inlet.

21–CI–01. 

Authority: We issue this notice under 

the authority of the MMPA (16 U.S.C. 

1361 et seq.). 

Peter Fasbender, 

Assistant Regional Director/Fisheries and 

Ecological Services, Alaska Region. 

[FR Doc. 2022–11849 Filed 6–1–22; 8:45 am] 

BILLING CODE 4333–15–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1009] 

Bulk Manufacturer of Controlled 

Substances Application: Bulk 

Manufacturer of Marihuana: Nusachi 

Labs, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: The Drug Enforcement 

Administration (DEA) is providing 

notice of an application it has received 

from an entity applying to be registered 

to manufacture in bulk basic class(es) of 

controlled substances listed in schedule 

I. DEA intends to evaluate this and other 

pending applications according to its 

regulations governing the program of 

growing marihuana for scientific and 

medical research under DEA 

registration. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 


jspears on DSK121TN23PROD with NOTICES1
33514 Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before August 1, 2022. 

ADDRESSES: DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment.’’ 

SUPPLEMENTARY INFORMATION: The 

Controlled Substances Act (CSA) 

prohibits the cultivation and 

distribution of marihuana except by 

persons who are registered under the 

CSA to do so for lawful purposes. In 

accordance with the purposes specified 

in 21 CFR 1301.33(a), DEA is providing 

notice that the entity identified below 

has applied for registration as a bulk 

manufacturer of schedule I controlled 

substances. In response, registered bulk 

manufacturers of the affected basic 

class(es), and applicants therefor, may 

submit electronic comments on or 

objections of the requested registration, 

as provided in this notice. This notice 

does not constitute any evaluation or 

determination of the merits of the 

application submitted. 

The applicant plans to manufacture 

bulk active pharmaceutical ingredients 

(API) for product development and 

distribution to DEA registered 

researchers. If the application for 

registration is granted, the registrant 

would not be authorized to conduct 

other activity under this registration 

aside from those coincident activities 

specifically authorized by DEA 

regulations. DEA will evaluate the 

application for registration as a bulk 

manufacturer for compliance with all 

applicable laws, treaties, and 

regulations and to ensure adequate 

safeguards against diversion are in 

place. 

As this applicant has applied to 

become registered as a bulk 

manufacturer of marihuana, the 

application will be evaluated under the 

criteria of 21 U.S.C. 823(a). DEA will 

conduct this evaluation in the manner 

described in the rule published at 85 FR 

82333 on December 18, 2020, and 

reflected in DEA regulations at 21 CFR 

part 1318. 

In accordance with 21 CFR 

1301.33(a), DEA is providing notice that 

on March 16, 2022, Nusachi Labs, LLC, 

2909 Armory Drive, Nashville, 

Tennessee 37204, applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substances: 

Controlled substance Drug 

code Schedule 

Marihuana Extract ........... 7350 I 

Marihuana ........................ 7360 I 

Tetrahydrocannabinols .... 7370 I 

Kristi O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–11826 Filed 6–1–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–954] 

Bulk Manufacturer of Controlled 

Substances Application: Sigma Aldrich 

Research Biochemicals, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Sigma Aldrich Research 

Biochemicals, Inc. has applied to be 

registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 1, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 1, 2022. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on December 29, 2021, 

Sigma Aldrich Research Biochemicals, 

Inc., 400–600 Summit Drive, Burlington, 

Massachusetts 01803, applied to be 

registered as a bulk manufacturer of the 

following basic classes of controlled 

substances: 

Controlled substance Drug code Schedule 

Cathinone ........................................................................................................................................................................ 1235 I 

4-Methyl-N-Methylcathinone ............................................................................................................................................ 1248 I 

Methaqualone .................................................................................................................................................................. 2565 I 

JWH–018 & AM678 ......................................................................................................................................................... 7118 I 

1-(5-Fluoropentyl)-3-(1-Naphthoyl)Indole ........................................................................................................................ 7201 I 

Lysergic Acid Diethylamide ............................................................................................................................................. 7315 I 

Tetrahydrocannabinols .................................................................................................................................................... 7370 I 

Mescaline ......................................................................................................................................................................... 7381 I 

2,5-Dimethoxyamphetamine ............................................................................................................................................ 7396 I 

3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I 

Alpha-Methyltryptamine ................................................................................................................................................... 7432 I 

Dimethyltryptamine .......................................................................................................................................................... 7435 I 

5-Methoxy-N,N-Diisopropyltryptamine ............................................................................................................................. 7439 I 

1-Benzylpiperazine .......................................................................................................................................................... 7493 I 

2-(2,5-Dimethoxyphenyl)Ethanamine .............................................................................................................................. 7517 I 

3,4-Methylenedioxypyrovalerone ..................................................................................................................................... 7535 I 

3,4-Methylenedioxy-N-Methylcathinone .......................................................................................................................... 7540 I 

Heroin .............................................................................................................................................................................. 9200 I 

Normorphine .................................................................................................................................................................... 9313 I 

Norlevorphanol ................................................................................................................................................................ 9634 I 

Acetyl Fentanyl ................................................................................................................................................................ 9821 I 

Amphetamine ................................................................................................................................................................... 1100 II 


jspears on DSK121TN23PROD with NOTICES1